Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-003241
Filing Date
2024-11-20
Accepted
2024-11-20 18:04:00
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3547
  Complete submission text file 0000905148-24-003241.txt   5016
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address
Nguyen AnhCo (Reporting) CIK: 0001977970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 241481607